Evommune Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	May '26 May 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Cap	824	540	-	-
Enterprise Value	621.39	391.78	0	0
Last Close Price	22.87	17.12	-	-
PS Ratio	82.37	41.51	-	-
PB Ratio	2.70	2.63	-	-
P/TBV Ratio	1.06	0.51	-	-
EV/Sales Ratio	62.14	30.14	-	-
Debt / Equity Ratio	0.02	0.01	0	0.01
Net Debt / Equity Ratio	-0.67	-0.72	0.50	1.00
Net Debt / EBITDA Ratio	2.30	1.85	1.04	2.11
Net Debt / FCF Ratio	2.53	1.93	1.23	2.59
Asset Turnover	0.04	0.09	0.09	0.06
Quick Ratio	19.94	8.33	2.57	11.53
Current Ratio	20.36	8.57	2.64	11.67
Return on Equity (ROE)	-29.79%	-54.42%	-112.09%	-47.52%
Return on Assets (ROA)	-32.88%	-53.87%	-88.45%	-46.02%
Return on Invested Capital (ROIC)	-112.03%	-341.60%	1029.83%	1445.21%
Return on Capital Employed (ROCE)	-34.69%	-63.56%	-113.41%	-50.20%
Buyback Yield / Dilution	-829.54%	-306.86%	-20.35%	-
Total Shareholder Return	-829.54%	-306.86%	-20.35%	-

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q